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INTRODUCTION
Anaemia  in  pregnancy  exists  world  over  but  it  is  a  very  common 
problem  in  most  of  developing  countries.  Anaemia  is  major  public  health 
problem in economically disadvantaged segments of population in developing 
countries.
In country like India it is frequently severe and contributes to maternal 
mortality and reproductive healthy morbidity. It deserves more attention than 
what it is currently receiving. Recently lot of programmes have been focused 
on safe motherhood but maternal anaemia remains a problem of great concern.
Gender discrimination is  another important  factors  in India and other 
Asian countries  the girl  child right from birth is  denied of proper food and 
education which leads to iron deficiency anaemia during pregnancy.
Magnitude of the Problem
The world wide prevalence of anaemia in pregnant women is estimated 
at  51%,  WHO  states  that  35%  to  75%  of  pregnant  women  in  developing 
countries and 18% of women in Industralised countries are anaemic.
In  India,  the  incidence  of  anaemia  among  expectant  mothers  is 
alarmingly  high  with  haemoglobin  level  less  than  10  gm%,  15  to  30% of 
maternal deaths are due to anaemia.
In areas where malaria and hookworm infestation is endemic prevalence 
of anaemia is high as 90%. The incidence of anaemia in adolescent girls in 
slum areas estimated to 98% this adversely affect reproductive performance.
The  prevalence  of  anaemia  has  come  down  due  to  fortification, 
prophylactic  iron  supplementation,  better  health  care  programme  aimed  at 
women and children.
AIM OF THE STUDY
To compare the efficacy of
Various Oral Iron
a. Ferrous sulphate
b. Sodium Feredetate (Sodium Iron EDTA)
c. Carbonyl iron
Parental Iron
a) Iron Dextran (Imferon)
In moderately anaemic pregnant women belonging to 24 to 32 weeks of 
gestational age.
NEED FOR THE STUDY
Anaemia  is  the  most  important  complication  in  pregnancy  in  the 
developing countries not only because of its greatly increased incidence but 
also because of its severity (Agarwal A.K. et al, 1999).   
Several  studies  reveal  that  socioeconomic  cultural  factors  influence 
dietary inadequacy during pregnancy which is attributed to poor purchasing 
power,  literacy,  ignorance,  regarding  nutritive  value  of  readily  available 
cheaper  food stuffs,  cultural  taboos,  superstitions  and large  family  (Menon 
Krishna et al, 1995, Ruth Bannet and Brown linding 1993, Naik D, jayashree  
1992). Nutritional iron deficiency anaemia is a serious problem in pregnancy 
which affects 90% pregnant women.
Severe  forms  of  anaemia  in  the  third  trimester  of  pregnancy  are 
invariably associated with cardiac failure. Highest maternal mortality rate in 
developing countries is due to severe anaemia, contributing to 20% death both 
directly and indirectly. It is also responsible for incidence of premature and low 
birth  weight  babies  thus  increasing  perinatal  and  infant  mortality  and 
morbidity.
According to Hassan Masood 1991, anaemia is prevalent among 50% - 
90% pregnant  women  especially  in  India,  which  is  the  number  one  killer. 
Despite  considerable  improvement  and  awareness  in  antenatal  care  in 
developing countries and inspite of national anaemia propylaxis programme in 
India  anaemia remains  a problem of  great  concern  with regard to  maternal 
morbidity, mortality and adverse outcome (Singh Kishore C et al, 1995).
Due to above stated reasons this study emphasis on regular antenatal 
check up, to screen for anaemia during every check up detect it earlier so that it 
can be treated adequately before the mother reaches term gestation. The goal of 
the treatment is to increase the haemoglobin status as rapidly as possible.
REVIEW OF LITERATURE
Definition of Anaemia
Anaemia is a condition of low circulating haemoglobin (Hb) in which 
the  Hb  concentration  has  fallen  below  a  threshold  lying  at  two  standard 
deviations all below the median of healthy population of the same age, sex and 
stage of pregnancy.
WHO  definition  for  diagnosis  of  anaemia  in  pregnancy  is  a  Hb 
concentration of less than 11gm/dl and a haematocrit of less than 33, although 
CDC (Centres for Disease Control USA) proposes a cut off point of 10.5gm/dl 
during the second trimester.
Severity of Anaemia
  The Indian Council of Medical research uses four categories of anaemia 
depending upon the haemoglobin levels in their study are
S.No. Category Hb Status g/dl
1. Mild 10 – 10.9
2. Moderate 7 – 10
3. Severe < 7
4. Very Severe (Decompensated) < 4
Causes of Anaemia
I. Physiological anaemia or hydremia of pregnancy
II. Pathological Anaemia
a. Nutritional – Iron, folic acid, Vit B12, Protein
b. Hemarrhagic
Acute - Following  bleeding  in  early  pregnancy,.  H/o. 
abortion or vesicularmole previously 
Chronic- Hookworm  infestation,  bleeding  haemarhoids, 
ulcerative colitis, malignancies
c. Haemolytic
Familial Haemoglobinopathies
Acquired Malaria, Severe Infection 
d. Bone Marrow insufficiency
Hypoplasia  or  aplasia  due  to  radiation,  drugs  (aspirin, 
indomethacin)
CAUSES OF NUTRITIONAL ANAEMIA DURING PREGNANCY
Nutritional  anaemia is believed to be the most widespread nutritional 
disorders  in the world.  It  essentially affects  people in developing countries. 
According to WHO 500 million to 1 billion individuals representing 15 to 20 
percent of worlds population is presently affected by this condition.
According to WHO definition, the “nutritional anaemia” encompasses 
all  pathological  conditions  in  which  the  blood  haemoglobin  concentration 
drops  to  an  abnormally  low level  owing  to  a  deficiency  in  one  or  several 
essential nutrients, regardless of the cause of this deficiency.
The etiology of nutritional deficiency of iron in developing countries is 
multifactorial.  The  causes  include  nutritional  deficiency  of  iron,  folate  and 
vitamin  B12,  secondary  effects  of  infections  and  parasitic  infestation.  An 
imbalance occur as a result of low nutrient intake, poor absorbtion, increased 
demand of nutrients during pregnancy, increased nutrient loss due to repeated 
pregnancies,  short  birthinterval  and  menstruation.  Dietary  short  coming  are 
often associated with low socio economic status and related to cooking and 
dietary habits, local food taboons, ignorance, illiteracy and lack of knowledge 
regarding nutrition (Van De, 1998).
 
The etiological factors of nutritional anaemia in pregnancy.
a) Dietary factors
b) Increased demand during pregnancy
c) Maternal causes
d) Sociocultural factors
e) Infections and Infestation
a) Dietary factors
Inadequate intake of food 
a. Low nutrient intake is the commonest cause of nutritional anaemia
b. Main nutrients involved in synthesis of haemoglobin are iron, folic 
acid, Vit B12 and deficiency of these cause anaemia  
Low iron absorption
Poor absorption and utilization of iron in the body is one of the causes of 
iron deficiency anaemia during pregnancy.
Factors decrease Iron absorption
a. Phytates
b. Calcium
c. Tannins
d. Tea and coffee
e. Herbal drinks
f. Fortified iron supplements
b) Increased Demand during pregnancy
Increased demand for nutrients is one of the major causes of nutritional 
anaemia  during  pregnancy  (Bucksher  et  al.,  1996).  The  increased  blood 
volume during pregnancy results  in dilution of red cells  and a reduction in 
haemoglobin concentration. This dilutional anaemia is potentially accentuated 
by the increased demands of iron and folic acid leading to anaemia.
Poor  absorption  of  iron  occurs  due  to  the  fact  that  Indian  diet  is 
predominantly cereal based.
Though  Indian  diet  has  adequate  iron  content  20  –  25mg/day  several 
factors  inhibits  absorption,  the  most  important  being  the  phytate  from  the 
cereals. Deficiency of ascorbic acid and calcium inhibits iron absorbtion.
Factors Affecting Absorption
Factors increase absorption
a. Hydrochloric acid by favouring dissolution and reduction of ferric iron.
b. Reducing  substance  like  ascorbic  acid,  aminoacids  containing 
sulphydryl radical, these reduce ferric to ferrous iron.
c. Meat contain organic iron and increased HCL secretion
d. Food containing low phosphorus diet.
There is increased demand for iron as it  is  essential for the synthesis of 
increased haemoglobin required for the greater maternal blood as well as for 
the storage of iron in the fetus. When the mother does not meet this demand, 
she may develop features of iron deficiency anaemia. It is needed not only to 
compensate the usual losses in urine, faeces, cutaneous desquamation (around 
0.5  –  1  mg  per  day)  but  also  to  cover  the  various  pregnancy  related 
expenditure. Total 1000 mg of iron is required. This represents an extremely 
large  amount  to  meet,  if  not  looked  after  it  can  result  in  iron  deficiency 
anaemia (Hercubury 1991).   
The requirements of iron is not confined only to those aspects of the fetus 
but also the placenta, the enlarged uterus and for increased volume that occurs 
during pregnancy.
The estimates of iron requirements  are
Foetus : 400 mg
Placenta : 100 mg
Uterus : 50 mg
Hb : 320mg
Total : 870 mg
c. Maternal Causes 
Depletion of nutrients occur in maternal body due to various reasons. 
The women may have entered pregnancy with compromised or  absent  iron 
stores. When further iron depletion occurs with advancing gestation anaemia 
results (Zuspan and Huilligun, 1994). 
In tropics frequent pregnancies are the common cause of iron and folic 
acid deficiency anaemia among pregnant mother  (Buckshee et al 1996). Iron 
depletion occurs due to uncompensated menstrual loses and chronic blood loss 
due to repeated pregnancies
Grand  multipara  is  considered  as  one  of  the  cause  contributing  to 
nutritional  anaemia  during  pregnancy  as  it  is  associated  with  increased 
incidence of disorders like hypertension, antepartum haemorrhage and others. 
The co-existing pathological condition like APH, PPH, abortions lead to iron 
deficiency results in iron deficiency anaemia (Buckshae et al, 1996) (Modak et  
al 1994).
There  are  maternal  causes  which  lead  to  nutritional  anaemia  during 
pregnancy. These are
a. Anaemia in multigravida or multipara is mainly due to blood loss in 
previous deliveries or pregnancies.
b. Repeated abortions, APH, PPH
c. Extra demand for iron, folic acid in multiple pregnancy
d. Short interval between pregnancies
i. Less  storage  of  iron  in  the  mothers  body  since  it  is  already 
utilized by the previous pregnancy.
ii. There  is  no time for  storage of  iron  in  the  body for  the  next 
pregnancy
d) Socio Cultural Factors
i. Poor Socioeconomic Status 
As the women continue to be a socially disadvantaged group, their poor 
status affects nutrition.
ii. Cultural belief, Cooking and Eating habits food taboos
Cultural practices play an important role in cause of nutritional anaemia 
in pregnancy. Because of taboos the pregnant mothers avoid meat, fish, egg, 
jaggery, curds, milk and leafy vegetables. Over cooking of food, washing of 
vegetables several time may lead to loss of nutrients in the food. This may also 
lead to nutritional anaemia in pregnancy (Vande 1998).
e. Infection and Infestation
i. Hookworm infestation
Hookworm infestation is considered as one of the cause of nutritional 
anaemia among the pregnant women (Agarwal et al, 1999).
Infestation  with  hookworm,  roundworm  and  whipworm  cause  or 
aggravate iron deficiency anaemia (Sephension 1994).
Hookworm  infestation  also  leads  to  the  deficiency  of  folic  acid  in 
pregnant women (Buckshee et al 1996).
ii. Malaria
Plasmodium  falciparam  cause  profound  anaemia  during  an  acute 
infection among pregnant women (Agarwal et al, 1999). 
Erythropoiesis
In human embryo haemopoiesis is first evident in yolk sac at 2 months, 
liver at 3rd month and to some extent spleen between 3rd and 6th month. Bone 
marrow activity begins by 4th and 6th month, it completely take over the process 
of haemopoiesis.
At birth bones are filled with red marrow, by 7 years marrow in long 
bones is less active, by age of 10 to 14 years fatty marrow extends proximally 
and 18 years normal adult distribution of marrow is in the skull, axial skeleton, 
pelvis  shoulder,  sternum ribs  and  with  extension  of  proximal  ends  of  long 
bones.
Stages of Erythropoiesis
i. Basophyllic proerythroblast
ii. Early normoblast
iii. Intermediatenormoblast
iv. Late normoblast
v. Reticulocyte
vi. Erythrocyte
Kinetics of Erythropoiesis
The time taken for erythropoiesis in human beings is about 7 days. The 
first  5  days  are  occupied  by  division  and  maturation  upto  non  nucleated 
reticulocytes in the marrow and the reticulocytes normally mature for another 
24 hours in the peripheral blood and spleen, after which it circulate for 120 
days. Since about 1% of circulating erythrocytes are destroyed each day, same 
number are formed and released. Factors regulating erythropoiesis
a) Androgen stimulates, esterogen suppresses erythropoiesis
b) Thyroidhormone and adrenocrotical steroids stimulates erythropoiesis
c) Nutritional  factors  like  proteins,  Vit  B12,  folic  acid,  Vit  B6,  riboflavin, 
pantothenic acid, nicotinic acid, ascorbic acid, Vit E, mineral like copper 
cobalt, zinc and iron.
IRON COMPARTMENTS IN HUMAN
Haemoglobin :  1ml of packed RBC contain 1mg of iron and size of this 
compartment changes in anaemia
Storage : Ferritin and Haemosiderin
Ferritin  :  It  is  a  water  insoluble  complex  of  ferrtic  hydroxide  and  protein 
apoferritin. Uptake and release of iron by ferritin is very rapid. Ferritin occurs 
in  all  cells  of  the  body.  Its  concentration  correlates  with  iron  store. 
Hamosiderin  water  soluable  compound  found  predominantly  in  cells  of 
monocytes macrophage system
Myoglobin : Present in all skeletal and cardiac muscles cells  
Transport Iron :
Active  transport  process  explained  by  “Mucosal  Block  Theory”. 
According to this theory ferrous form absorbed in small intestine converted to 
ferric form in the intestinal villi  this combine with apoferritin in the villous 
epithelial cell to form ferritin.
Absorption of iron is controlled by the availability of apoferritin. If this 
is fully saturated no more iron is absorbed, and this protects from excessive 
absorption in anaemia. In anaemia excess ferritin is brokendown make more 
apoferritin available and thereby augments iron absorption. This intracellular 
ferritin  is  eventually  excreted  following  desquamation  of  epithelial  cells  of 
intestine.
IRON TRANSPORT AND UTILIZATION
Iron  after  absorption  circulate  in  the  blood bounded to  a  β globulin 
transferin which is normally 1/3 saturated with iron. Normal iron varies from 
66 – 140 microgram / 100 mg plasma.
Physiological changes in Haemoglobin during pregnancy 
 In pregnancy there is progressive increase in circulating blood volume 
due to increase in plasma and RBC volume
Increase blood volume ranges from 30 – 70% of the non pregnant level.
Increased  blood volume due  to  maternal  size,  level  of  placental  and 
extraplacental  hormones  and erythropoietin,  influence  the  increase  in  blood 
volume.
The increase in plasma volume is 40 – 50%.
The increase in RBC volume is 20%.
Anaemia during pregnancy is a consequence primarily of expansion of 
plasma volume without normal expansion of maternal haemoglobin.
This is called physiological anaemia because
i. It begins in I trimester when the iron needs are fullymet.
ii. Occurs in well nourished women 
Physiological Anaemia Occurs Because
i. Increase in plasma volume and RBC volume occur at different 
periods of pregnancy.
ii. Plasma  volume  begins  to  rise  at  6  –  8  weeks  of  pregnancy 
reaches peaks at about 32 weeks after it plateaus
iii. The rise in RBC volume begins at 20 weeks and continue till 
term. There is trend for mean Hb fall  in the first  and second 
trimester  and  little  rise  later  in  the  third  trimester  (Peckand 
Ariyas 1979).   
Haematological Parameters 
Normal blood values in non pregnant status
RBC - 4.8 – 6 million / cumm
Hb - 12 – 14 gm / dl
PCV - 40 – 45%
Life span of RBC is 110 – 120 days
Normal blood values during pregnancy
RBC - 4.5 million / cumm
Hb - 12 – 13.4 gm/dl
PCV - 37 – 42%
MCV - 80 – 90 cubic microns
MCHC - 28 – 34%
MCH - 27 – 32 Picogram
Colourindex - 0.9 - 1
Mean corpuscular Hb MCH =
Hb in gm per 1000ml blood
RBC in million /cumm
Normal = 29.5 pico gm
  
Mean corpuscular Volume MCV =
Volumes of packed cell per 1000ml
RBC in million /cumm
Normal = 68 cubic microns
Mean corpuscular Hb 
concentration MCHC =
Hb in gm per 100 ml 
Volume of packed cell per 100 ml
X 100
Normal = 34 percent
Colour index =
Hb (percentage of normal)
RBC (percentage of normal)
Normal = 0.9 - 1
SYMPTOMS AND SIGNS:
Symptoms:  complaints of fatigue, poor tolerance of exertion, weakness and 
lassitude.  Other features are anorexia and indigestion; palpitation caused by 
ectopic beats, dyspnoea, giddiness, and swelling of legs.
Signs:
Pallor:
Pallor  of  varying  degree  is  evident.  The  colour  of  the  lips,  tongue, 
innerside of the lower eyelid, palms, and sole are pale. If the colour of palmar 
creases are as pale as the surrounding skin the haemoglobin is usually less than 
7 gm/dl.
Nailbed should be examined for pallor, the rapidity of capillary refill is 
an indicator of integrity of the cardiovascular system.
Koilonychia:
Koilonychia  is  strongly  suggestive  of  Iron  deficiency  and  is 
demonstrated as spoon shaped nails.
Glossitis: 
Ulceration in the mouth and tongue. The painful dry tongue of glossitis 
is helpful in diagnosing Vit B12 deficiency anaemia. Angular stomatitis is also 
associated.
Oedema legs:
This is due to hypoproteinemia.
Cardiovascular changes:
Cardiovascular signs reflect decompensation a soft systolic murmur may 
be heard in mitral area due to mitral incompetence. Crepitation may be heard at 
the base of lungs due to congestion.
Investigation:
1. Maternal condition.
2. Fetal condition.
Maternal condition: a) Type and degree of severity. The investigations include,
a) Hb%
b) RBC count.
c) PCV.
d) Blood indices.
MCV – Normal 78 – 92 cu micron.
< 78 microcytic suggest iron def.
> 92 macrocytic follate def.
MCH – Normal 28 – 33 pgm.
↓ in iron def anaemia.
MCHC – 33 – 36%
↓ in iron def anaemia.
Peripheral smear:
This simple investigation often throws light on the etiology.
a) Microcytic hypochromic cells.
b) Macrocytic hyperchromic cells.
c) Normocytic normochromic cells.
1) Microcytic hypochromic cells are  seen in,
a) Iron deficiency.
b) Thalessemia.
c) Sideroblastic anaemia.
d) Anaemia of chronic disease.
e) Lead poisoning.
f) Copper poisoning.
2) Macrocytic hyperchromic cells:
a) follate/vit B12 deficiency.
3) Normocytic normochromic.
b) other causes or early nutritional deficiency.
4) Schisto/aniso and poikilocytes:
Haemolytic anaemia.
5) Target cells:
Thalessemia.
MICROCYTIC HYPOCHROMIC BLOOD PICTURE 
NORMOCYTIC HYPOCHROMIC 
6) Sickle cells:
Sickle cell anaemia.
7) Hypersegmented polymorphs:
Seen in megaloblastic anaemia.
8) Platelet:
   May be decreased.
9) Parasites:
Such as malaria and leishmania may be seen.
B. Investigation for etiology.
Urine examination:
Urine albumin, sugar and deposits, and urine culture and sensitivity to 
rule out  infection.
Stool examination:
- Parasites (ova of hookworm).
- Occult blood loss.
C. SPECIAL INVESTIGATIONS
I. Ferrokinetics:
These are tests that confirm the diagnosis and severity of iron deficiency 
anaemia.
a) Serum ferritin.
Abnormal when < 15 ngm/ml.
b) Serum transferrin iron binding capacity.
Normal 300 – 360 g/ml. Value increases with severity of anaemia.
c) Serum iron.
Normal 65-165 gm/dl. It is ↓ in iron def anaemia.
d) Percentage saturation of transferrin.
Normal 35 – 50%. This value is ↓ 15% in iron def anaemia.
e) RBC protoporphyrin  –  30  gm/dl.  This  value  is  found doubled  or 
tribled.
f) Total iron binding capacity.
Increased up to 550 gm/dl or even more.
II.  Investigations Of Megaloblastic Anaemia
MCV 110 – 140 cu/microns.
MCH 33- 36 pg.
Serum follate < 3 gm/litre.
RBC follate < 80 gm/litre.
Serum vit B12.
Peripheral smear macrocytic and hypersegmented.
Serum B12.
Buffy coat.
FIGLU test.
III. Investigation in hemolytic anaemia.
a) Osmotic fragility.
b) Coombs test.
c) Haemoglobin electrophoresis.
IV. Tests to ensure therapy.
1. Reticulocyte count – increases.
2. Haemoglobin - increases.
3. Peripheral smear - ↓ in abnormal cell type.
V.  Screening test.
Haemoglobin must be determined by Sahlis haemoglobin  method at the 
first  antenatal  visit.  It  should be repeated in all  antenatal  visit  ideally at 32 
weeks gestation when their haemodilution is at its peak.
Effects of nutritional anaemia during pregnancy.
Nutritional anaemia among pregnant women is associated with adverse 
consequences to both the mother and the foetus.  These adverse effects vary 
upon  the  severity  of  anaemia  and  presence  of  other  obstetric  or  systemic 
problems in anaemic women ( Lewis and Chamberlin 1999).
Effect on the mother:
1. Iron  deficiency  anaemia  among  pregnant  women  leads  to 
diminished  work  capacity,  physical  performance,  and 
neurological dysfunction.
2. More prone for infections.
3. Antepartum and postpartum haemorrhage are more common 
in anaemic mothers.
4. Antenatal mothers go for cardiac failure during labour.
5. Puerperal pyrexia.
6. Puerperal sepsis.
7. Subinvolution.
8. Lactation failure.
9. Episiotomy wound gaping and abdominal wound gaping.
10. Abortion.
11. Folate deficiency leads to PIH, abruptio placentae.
12. Maternal and perinatal morbidity and mortality increases 
Effect on fetus
Nutritional anaemia due to iron and folic acid deficiency is the cause of 
abortion,  premature  birth,  low  birth  weight,  foetal  wastage  like  abortion, 
intrauterine death, and stillbirth occur in about 20% of the conception due to 
anaemia (Sethi et al. 1991) (Kelton et; 1988) IUGR, impaired learning ability 
in children.
• Folic  acid  deficiency  has  been  implicated  as  a  cause  of  foetal 
malformation especially neural tube defects.
• Maternal iron deficiency anaemia leads to lower iron rescue in infancy.
• Severe nutritional anaemia among pregnant mother leads to increased 
risk of intrauterine hypoxia, higher perinatal and neonatal mortality and 
morbidity.
PREVENTION OF IRON DEFICIENCY ANAEMIA
Prophylaxis of non pregnant women:
Girls  in  India  are  deprived of  good diet.  As most  women start  their 
pregnancy with anaemia or low iron stores, prevention should start even before 
pregnancy. The women of child bearing age should receive 60 mg of iron daily 
for 2 – 4  months along with follic acid to prevent neural tube defects.
Iron supplementation during pregnancy
The ministry of health government of India now recommended intake of 
100 mg of elemental iron 500 µgm folic acid in the second half of pregnancy 
for a period of at least 100 days.
Treatment of hookworm infestation:
Single dose albendazole 400 mg or mebendazole 100 mg twice daily for 
3  days  with  iron  supplementation  should  be  given  to  all  anaemic  pregnant 
women.
4.   Improvement of dietary habits
Pregnant  woman  should  eat  foods  rich  in  iron  jaggery,  green  leafy 
vegetables like spinach, mustard leaves, turnip green, cereals, sprouted pulses. 
Avoid tea and coffee intake, too much cooking should be avoided.
5. proper antenatal care.
a) antenatal  mothers  should  have  regular  antenatal  checkup  which  should 
begin in first  trimester of pregnancy.
b) HB% estimation should be done during every A.N visit.
c) Iron and folic acid should be consumed daily.
d) Proper treatment of infection.
6. Health education
1. By limiting number of children 1 to 2.
2. The ideal interval between 2 successive pregnancy should be 3 year.
3. Ideal age for child bearing is 20 – 25 yrs.
TREATMENT OF IRON DEFICIENCY ANAEMIA
Oral iron therapy
If the women presents with in mid trimester or early third trimester with 
anaemia oral iron is started. Plenty of iron preparation are available each with 
own advantages and disadvantages.
DOSAGE:
Ferrous  sulphate  tablets  are  used  in  all  government  hospital  for  oral 
treatment of anaemia. For treatment more than 180 mg of elemental iron per 
day  is  required.  Two tablets  of  ferrous  sulphate  each  containing  100mg of 
elemental iron per day is required for treatment.
Side effect:
Upto 10% of women may have side effects with oral iron in the form of 
gastrointestinal symptoms such as nausea, vomiting, constipation, abdominal 
cramping and diarrhea which are dose related. Side effects can be minimized 
by advising to take the tablet with food.
Response to treatment:
The patient’s response to 180 mg elemental iron per day is fast with 
significant increase in HB from 0.3 to 1 gm per week. Reticulocytosis occur 
within 5 – 10 days of treatment.
Duration of treatment:
Treatment  should  be  continued  until  the  blood  parameter  become 
normal after which a maintenance dose of 1 tablet per day should be continued 
for at least 3 months after delivery.
Disadvantage of oral iron treatment:
a) Intolerance to medication.
b) Noncompliance.
c) Unpredictable absorption.
d) Haemoglobin  concentration  restored  with  therapeutic  dose  but 
replenishing iron stores required treatment for longer periods.
If  there  is  no  significant  clinical  or  haematological  improvement  within  8 
weeks diagnostic reevaluation is needed. Reasons for failure to oral therapy 
involve  inaccurate  diagnosis  of  non  iron  microcytic  anaemia  such  as 
thalessemia, pyridoxine deficiency, lead poisoning, continuous loss of blood 
through hookworm infestation,  Co-existing infection,  faulty  iron absorption, 
concominant folate deficiency.
a. FERROUS SULPHATE
    Ferrous sulphate tablets available in Government Hospital contains 100mg 
of elemental iron.
b. CARBONYL IRON
Carbonyl  iron  is  a  pure  form  of  elemental  iron  that  contains  98% 
mineral iron which is a small particle preparation of highly purified metallic 
iron.  It  is  a  form  of  elemental  iron  produced  by  a  chemical  carbonyl 
decomposition process. Carbonyl describes the process of manufacture of iron 
particles from iron penta carbonyl gas.
Bioavailability:
Carbonyl particles are small < 5µ and have large surface areas which 
results in improved bioavailability.
Carbonyl iron has been shown to be well absorbed and utilized in Hb 
synthesis. Its advantage includes environmental stability.
Safety Profile:
Carbonyl iron is much less toxic than ionized forms of iron. In humans 
lethal dose of ferrous sulphate is 200 mg/kg. In recent study no serious toxicity 
was reported in all patients with mean carbonyl iron ingestion of 11.2 mg/kg.
COMPARISON BETWEEN CONVENTIONAL IRON AND 
CARBONYL IRON PARTICLES
Side effects:
Carbonyl iron does not have many of the side effects associated with 
other iron products particularly ferrous sulphate such as GI irritation, nausea, 
constipation or diarrhea. There was no evidence of haematologic, hepatic, or 
renal toxicity.
Advantages of carbonyl iron:
i) It  is  98% pure form of  iron.  The percentage of  elemental  iron in 
carbonyl iron is 98%.
ii)  Unlike other  preparation it  is  inert  and incapable of  reacting with 
chelators  of  iron  such  as  transferrin  and  desferraxamine.
iii) It leads to a rapid rise in haemoglobin.
iv) It has a wide margin of safety.
v) It is free from gastric side effect.
vi) It is safest in pregnancy.
SODIUM FEREDETATE:
Synonyms: 
Sodium iron EDTA, sodium feredetate, edetic acid, sodium iron salt.
CHEMICAL NAMES: 
Sodium iron III ethylene diamine tetraacetate.
ABSORBTION OF SODIUM FEREDETATE
CHEMICAL FORMULA:
C10H12FeN2Nao8:3 H2O.
MECHANISMS OF ACTION:
Sodium  Feredetate  is  stable  in  acidic  environment  and  hence  no 
dissociation of sodium Feredetate complex takes place in stomach. It is only 
when  it  enters  the  duodenum  that  dissociates  into  EDTA  and  iron.  Iron 
absorption begins where iron is made available to the mucosal cells. The free 
EDTA then acts as a shuttle and picks up more iron, copper, zinc from the food 
and delivers into mucosal cells. Absorption of iron is not inhibited by other 
inhibitory ligands.
Excretion of EDTA:
95% of EDTA molecule is excreted in faeces and 5% in urine within 24 
hours.
PARENTERAL IRON
It  is  indicated in patients who cannot absorb iron, noncompliant or develop 
serious side effects with oral iron which cannot be corrected by simple means.
Iron deficit is calculated,
(normal Hb – patients Hb) x wt in Kg x 2.21 + 1000.
The parenteral iron is available as Iron dextran (Imferan) which can be given 
intramuscularly or intravenously. Iron sorbital citrate which can be only given 
intramuscularly.
IRON DEXTRAN INJECTION:
Iron  dextran  injection  is  a  collidal  solution  of  ferric  oxyhydroxide 
complexed with polymerized dextran that contain 50 mg/ml of elemental iron. 
It can be administered by either intravenous or intramuscular injection. When 
given  by  deep  intramuscular  injection  it  is  gradually  mobilised  via  the 
lymphatics and transported to reticuloendothelial cells.  Iron is released from 
the dextran complex.
INTRAMUSCULAR IRON:
Oral iron should be stopped before giving intramuscular  iron as it  is 
associated with toxic  reaction initially test dose of 1 ml of iron dextran is given 
deep intramuscularly if there is no reaction the injections are given daily or on 
alternative days in doses of  2 ml intramuscularly by using Z technique in the 
outer  quadrant  of  buttock.  Z  technique  involves  pulling  the  skin  and 
subcutaneous  tissues to one side before inserting the needle.
Advantages:
1. The main advantage is certainty of its administration to correct the Hb deficit 
and build up the iron stores.
Disadvantages:
1.  Pain,  skin discolouration,  and abscess  formation,  reaction in  the  form of 
nausea,  vomiting,  headache,  fever,  lymphadenopathy,  allergic  reaction  and 
rarely anaphylaxis.
Intravenous infusions
Total  iron  requirement  is  calculated  using  the  above  formula. 
Intravenous  infusion  should  be  given  in  the  hospital  setting  by  doctors  to 
patients  with  no  allergy  to  test  dose.  Injection  epinephrine,  hydrocortisone, 
oxygen should be available in the event of anaphylactic reaction. Iron dextran 
is diluted in normal saline or 5% dextrose and given slowly initially. If there is 
no reaction, it can be given faster. If the calculated dose is more than 250 mg, it 
should be given 2 doses on two consecutive doses. One should look for any 
reaction in the form of chest pain, rigor, chills, fall in blood pressure, dyspnoea, 
haemolysis, and anaphylactic reaction. For any such reaction, infusion should 
be stopped and antihistamine, corticoids, and epinephrine given.
Blood Transfusion
Blood transfusion is required in patients with severe anaemia beyond 36 
wks,  associated  infection,  to  replenish  blood  loss  due  to  antepartum  or 
postpartum haemorrhage and in patients not responding to oral or parenteral 
iron therapy. Packed cells are preferred for transfusion.
Blood transfusion may cause preterm labour,  precipitated labour,  and 
overloading of heart. Exchange transfusion is used very rarely in some centres 
for severe anaemia.
MANAGEMENT OF LABOUR IN ANAEMIC PATIENTS:
First stage:
Patient  should be in a comfortable  position.  Sedation and pain relief 
should be given. Oxygen should be kept ready and is given in dyspnoea. In 
case of preterm labour, betamimitics and steroids should be given with caution 
to avoid risk of pulmonary oedema.  Digitalization may be required in cardiac 
failure due to anaemia. The aim is to deliver vaginally.
Second stage:
The second stage is very stressful as the patients may go in for cardiac 
failure. Prolongation of second stage can be curtailed by forceps.
Third Stage:
Third  stage  must  be  energetically  treated  as  these  patients  tolerate 
bleeding very poorly. Prophylactic methergin should be given. Oxytocin 20 U 
infusion slowly given. Episiotomies wound should be sutured faster.
Puerperium:
During puerperium mother should have adequate rest. Iron and folate 
therapy  should  be  continued  for  at  least  3  months.  Any  infection  must  be 
energetically  treated.  The  anaemic  patient  must  use  an  effective  method of 
contraception and should not conceive for at least 2 years until the iron stores 
are replenished. Sterilisation is preferred if the family is completed. 
Several studies were done to compare the efficacy of different treatment 
using oral and parentral iron.
“A prospective partially randomized study of pregnancy outcomes and 
haemtologic responses to oral and intramuscular iron treatment in moderately 
anaemic pregnant women”. This was done in Moulana Azad Medical College, 
New Delhi,  Conducted  by  Jaib  Sharma,  Sandya  Jain,  Venkatesan  Mallika, 
Tejinder Singh, Ashok Kumar. This study compared the safety and efficacy in 
treating  pregnancy  anemia  with  intramuscular  iron  and  ferrous  sulphate. 
Changes in haemoglobin iron indicators, pregnancy outcomes and birth weight 
were compared between the 2 groups. The result obtained were serum ferritin 
concentration rise after parental iron treatment better than oral ferrous sulphate 
group.
Similar other studies :
1. “A novel rigime of intramuscular iron therapy” Srivastave Aarti,  Tanden 
Prabha,  Darvineta  conductdd  in  ICMR  Department  of  Obstetric  and 
Gynaecology  KGMU Lucknow.  In  this  study  200  mg iron  dextrin  was 
given to mildly anaemic pregnant women as deep intramuscular injection 
for 5 days. Then mean rise in haemoglobin after 4 weeks was significant 
than oral ferrous sulphate.
2. Iron dextron in the treatment of iron deficiency anaemia of pregnancy stein 
ML, Gunston KD, Mey RM.
3. New Schedule  of  intramuscular  iron  administration  for  pregnant  women 
Mahale AR, Shah SH.
Bioavailabilty  of  carbonyl  iron  a  randomized  double  blind  study 
Devasthali  SD, Gordeuk VR, Brittenham GM, Bravo JR,  Compared ferrous 
sulphate with carbonyl iron in blood donors. The study showed bio availability 
of Carbonyl iron was better with Carbonyl iron.
High dose carbonyl iron for iron deficiency anemia a randomized double 
blind trial Gordeuk, Brittenham. The study concluded that high dose carbonyl 
iron was well tolerated than standard ferrous sulphate in higher dosage.
In  food  and  nutrition  research  institute  Department  of  Science  and 
technology Manila,  study was conducted by Trinidad TP, Valdez, regarding 
iron absorption from Iron fortified rice with different forms of iron fortificant, 
ferrous sulphate, ferrous EDTA, ferrous fumarate and ferrous Bisglycinate and 
the study concluded NaFe EDTA showed a better iron absorbtion.
Similar other studies
a. Effectiveness of NaFe EDTA – fortified soy sause in controlling iron 
deficiency in China by Chen J Zhao
Regular consumption of NaFe EDTA fortified fish sauce improves iron status 
and  reduced  the  prevalence  of  anaemia  in  Vietnamese  common  They  PV, 
Berger J, Davidson L.
MATERIALS AND METHODS
The  study  was  conducted  from  February  2005  –  February  2006  in 
Hospital  for  Women  and  Children  Egmore  (Institute  of  Obstetrics  and 
Gynaecology) attached to Madras Medical College. 
The  antenatal  women  attending  the  antenatal  OP  are  screened  for 
Haemoglobin status. Those antenatal women of gestational age 24 – 32 weeks 
with hemoglobin between 8- 9.5gm% were selected 200 of those women was 
selected.
Exclusion criteria :
i. Women with diabetes, hypertension significant medical complication 
such as heart disease or any other systemic disease are excluded
ii. Gastro  intestinal  bleeding  or  malabsorbtion,  Bleeding  piles  and 
bleeding from any other site is excluded.
iii. Multiple pregnancy
iv. Previous blood transfusion
v. Recent administration of iron for treatment of anaemia
Investigation performed were
a) Haemoglobin estimation
b) Peripheral smear study
Determination of Haemoglobin level :
Sahlis Haemoglobino meter 
0.1N  HCl  was  sucked  by  an  ordinary  pipette  was  poured  into  the 
graduated dilution tube upto 20 mark on percentage side or 2 mark on gram 
percentage side. Blood was sucked by the haemoglobin pipette transfused to 
dilution tube containing. 0.1N HCl stirred with stirrer. The dilution tube was 
allowed to stand for 5 minutes. The colour of the dilution tube was compared 
with that of the standard in day light. Distilled water is added further to equal 
the colour of the mixture with standard, distilled water is added in succession 
of 3 – 4 drops and each time it was mixed with the stirrer. Towards the final 
point the number of drops may be reduced to get the right point accurately. The 
scale was read which gave the hamoglobin as gram %.
Peripheral smear :
Blood smear was stained with leishman stain morphology of redcells 
was noted.
 A written informed consent was obtained from the patient eligible to 
participate in the study.
 The patients eligible to participate were randomized to one of the four 
treatment groups. Randomization was done in such a way body mass index, 
gestational  age,  haemoglobin status  initially  was  equal  in all  four  treatment 
group.
After  selection  the  patients  were  subjected  to  detailed  history  and 
physical examinations and the findings were noted. Initial haemoglobin status 
and peripheral smear was noted.
All the women in the study group was given T – albendazole 400mg 
single dose.
 4 groups of treatment groups are
Group A Ferrous Sulphate Group
50 of the selected group received ferrous sulphate 100mg of elemental 
iron with folic acid 0.5mg tablet one tablet twice a day
Group B Sodium Feredetate Group
50 of the selected group received sodium feredetate 100 mg elemental 
iron with folic acid 0.5 mg twice a day
Group C Carbonyl Iron
50 of the selected group received carbonyl iron 100mg elemental iron 
with folic acid 0.5mg one tablet twice a day.
Group D Imferon Group 
Total iron requirement = (normal Hb – patient’s Hb) x wt in Kg x 2.21 + 1000
Normal Hb = 11gm% as per WHO standard 
Iron  requirements  was  calculated,  iron  dextran  injection  was  given 
according to requirement. 100mg per day daily till the requirement is met after 
test dose. The patients were advised to take follic acid tablet 5mg twice weekly.
Patients were evaluated apart from baseline at 2 week interval adverse 
effect if any reported were noted, whether the patient could tolerate oral iron is 
noted, and vital like blood pressure and pulse rate noted. The patient should 
bring back the empty packs of tablets and there were enquired about the colour 
of the stool.
At the end of 4 weeks repeat haemoglobin estimation was done. The 
results and data was analysed with statistical test.
If  the  haemoglobin  at  the  end of  4  weeks  was  11gm% then ferrous 
sulphate 100mg of elemental iron i.e., 1 tablet is continued till 3 months after 
delivery.  If the Hb is less than 11gm% ferrous sulphate 100mg of elemental 
iron one tablet twice a day is given till 11gm% is reached.
OBSERVATION AND RESULTS
Table -1 
GROUP A FERROUS SULPHATE
S.No. Initial Hb% 
gm%
No. of Patients Percentage
1. 8 – 9 23 46%
2. 9 – 9.5 27 54%
46% of the patient had initial Hb 8 – 9 gm%
54% of the patient had initial Hb 9 – 9.5 gm%
GROUP A FERROUS SULPHATE 
Table -2
SMEAR STUDY
S.No. Smear No. of Patients Percentage
1 Microcytic Hypochromic 33 66%
2 Normocytic Hypochromic 9 18%
3 Normocytic Normochromic 8 16%
66% of patient had microcytic hypochromic blood picture
18% of patient had normocytic hypochromic blood picture
16% of patient had normocytic normochromic blood picture
Table -3 
GROUP A FERROUS SULPHATE RISE IN Hb
S.No. Rise in Hb% gm% No. of patient Percentage
1 < 1 6 12%
2 1 – 1.5 35 70%
3 1.6 – 2 9 18%
In ferrous sulphate group 70% of the patient showed a increase of 1 – 
1.5 gm% 18% of the patients showed a increase of 1.6 – 2gm%. 12% of the 
patients  showed a increase of less than 1 gm%.
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FERROUS SULPHATE
Table -4 
GROUP A FERROUS SULPHATE SIDE EFFECTS
S.No. Side effect No. of patients Percentage
1. Epigastric pain 8 16%
2. Vomiting 2 4%
3. Constipation 4 8%
4. Metallic taste 4 8%
5. Diarrhoea 1 2%
6. Nil 31 62%
 
In ferrous sulphate group 62% of patients showed no side effect. 8% of 
patients had constipation and metallic taste. 2% had diarrhoea.
 
Table -5
GROUP B SODIUM FEREDETATE
S.No. Initial Hb%
gm%
No. of Patient Percentage
1 9 – 9.5 25 50%
2 8 – 9 25 50%
In sodium Feredetate 50% of the patients had 9 – 9.5gm% and another 
50% of the patients had 8- 9 gm%.
Table -6 
GROUP B : SMEAR STUDY SODIUM FEREDETATE
S.No. Smear No. of patients Percentage 
1 Microcytic Hypochromic 30 60%
2 Normocytic hypochromic 10 20%
3 Normocytic Normochromic 10 20%
60% of the patient had microcytic hypochromic blood picture.
Table -7
GROUP B : SODIUM FEREDETATE RISE IN Hb
S.No. Rise in Hb% (gm%) No. of patient Percentage of Patient
1 1- 1.5 25 50%
2 1.6 – 2 25 50%
In group B 50% of the patient had a rise of 1 – 1.5gm% and remaining 
50% of the patients showed a rise of 1.6 – 2 gm%.
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Sodium Feredetate
Table -8
GROUP B SODIUM FEREDETATE SIDE EFFECTS
S.No. Side effects No. of patients Percentage
1. Epigastricpain 6 12%
2. Vomiting 2 4%
3. Constipation 3 6%
4. Metallictaste 5 10%
5. Diarrhoea - -
6. Nil 34 68%
68%  of  patients  in  sodium  feredetate  group  showed  no  side  effect. 
Epigastric  pain  was  present  in  12% of  patient.  Vomiting,  constipation  and 
metallic taste contributes to 4%, 6% and 10% of the patients.
Table -9
GROUP C CARBONYL IRON INITIAL Hb%
S.No. Initial Hb% gm
%
No. of patient Percentage
1 8-9 24 48%
2 9 – 9.5 26 52%
In carbonyl group 48% of patient had initial hamoglobin value 8 – 9gm
%, 52% of the patient had initial haemoglobin value 9 – 9.5%.
Table -10 
GROUP C CARBONYL IRON SMEAR STUDY
S.No. Smear study No. of Patient Percentage of Patient
1 Microcytic Hypochromic 34 68%
2 Normocytic Hypochromic 13% 26%
3 Normocytic Normochromic 3 6%
68% of the patients had microcytic Hypochrmic blood picture.
Table -11
GROUP C CARBONYL IRON RISE IN Hb%
S.No. Rise in Hb gm% No. of patient Percentage
1 > 2 2 4%
2 1.6 – 2 30 60%
3 1 – 1.5 18 36%
In carbonyl iron group 60% of the patients had a rise in Haemoglobin 
1.6 – 2gm%. 4% of the patient had a rise of more than 2gm%, 36% of patients 
had rise of 1 – 1.5 gm%.
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CARBONYL IRON
Table -12
GROUP C : CARBONYL IRON SIDE EFFECTS
S.No. Side effects No. of patients Percentage
7. Epigastric pain 4 8%
8. Vomiting 1 2%
9. Constipation 2 4%
10. Metallictaste 6 12%
11. Diarrhoea 1 2%
12. Nil 36 72%
In carbonyl iron group 72% of the patient had no side effect 2% of the 
patients had diarrhoea and vomiting. 4% of the patients had constipation. 8% of 
patient had epigastric pain 12% of the patients had metallic taste.
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Table -13
GROUP D IMFERON INITIAL Hb
S.No. Initial Hb%
gm%
No. of patient Percentage
1 8-9 24 48%
2 9 – 9.5 26 52%
52% of  patient  had  initial  Hb 9  –  9.5gm%.  48% of  patient  had  initial  Hb 
8- 9gm%.
Table -14
GROUP D IMFERON SMEAR STUDY
S.No. Smear study No. of Patient Percentage of Patient
1 Microcytic Hypochromic 30 60%
2 Normocytic Hypochromic 18 36%
3 Normocytic Normochromic 2 4%
60%  of  the  patients  in  group  B  had  microcytic  hypochromic  blood 
picture.
Table -15
GROUP D IMFERON RISE IN Hb gm%
S.No. Rise in Hb gm% No. of patient Percentage
1 < 1.5 3 6%
2 1.5 – 1.9 17 34%
3 2 – 2.5 30 60%
In imferon group 60% of the patients had a rise in Haemoglobin 2 – 
2.5gm%.  34% of  the  patient  had  haemoglobin  rise  1.5  –  1.9gm% ,  6% of 
patient showed a rise of < 1.5gm%.
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IMFERON IRON
Table -16
GROUP D IMFERON GROUP SIDE EFFECTS
S.No. Side Effects No. of Patients Percentage
1. Pain at injection site 50 100%
2. Discolouration of skin
at injection site
20 40%
3. Arthralgia 5 10%
All the patient in imferon group had pain at injection site. 40% of the 
patients  had discolouration of skin at  the injection site,  10% of patient  had 
arthralgia.
ANALYSIS AND DISCUSSION
Analysis of data
a) Age
The mean age of patient in each group
Group A Ferrous Sulphate : 23.86
Group B Sodium Feredetate : 22.36
Group C Carbonyl Iron : 22.40
Group D Imferon : 23.80
Age Distribution 
 N Mean SD
ANOVA
 F-test
Ferrous Sulphate 50 23.36 4.144
Sodium Feredetate 50 22.36 3.397
Carbonyl Iron 50 22.40 4.111
Imferon Iron 50 23.06 3.291
F=0.87
P=0.46
Total 200 22.80 3.753
The age was analysed by ‘F test’ the difference was not significant.
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Analysis of Body Mass index :
The Mean Body Mass index in each group 
Group A Ferrous Sulphate : 23.40 kg/m2
Group B Sodium Feredetate : 22.92 kg/m2
Group C Carbonyl Iron : 23.08 kg/m2
Group D Imferon : 23.05 kg/m2
BMI
 N Mean
Std. 
Deviation
ANOVA
 F-test
Ferrous Sulphate 50 23.40 3.220
Sodium 
Feredetate 50 22.92 2.578
Carbonyl Iron 50 23.08 3.185
Imferon Iron 50 23.05 2.734
F=0.46
P=0.87
Total 200 23.11 2.926
This was also analysed with ‘F Test’, F – 0.46, P – 0.87.
The difference was not significant.
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Analysis of Gestation age :
The mean gestational age  in each group 
Group A Ferrous Sulphate : 27.40 weeks
Group B Sodium Feredetate : 27.44 weeks
Group C Carbonyl Iron : 27.48 weeks
Group D Imferon : 27.54 weeks
Gestation Age 
 N Mean
Std. 
Deviation
ANOVA
 F-test
Ferrous Sulphate 50 27.40 2.921
Sodium Feredetate 50 27.44 2.998
Carbonyl Iron 50 27.48 2.880
Imferon Iron 50 27.54 2.991
F=0.46
P=0.87
Total 200 27.47 2.926
The difference was not significant
F = 0.46
P = 0.87
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Analysis of Initial Haemoglobin
Mean Initial Haemoglobin in Each Group
Group A Ferrous Sulphate : 8.854 gm%
Group B Sodium Feredetate : 8.770 gm%
Group C Carbonyl Iron : 8.808 gm%
Group D Imferon : 8.712 gm%
Initial HB 
 N Mean Std. Deviation F-test
Ferrous 
Sulphate 50 8.854 .4509
Sodium 
Feredetate 50 8.770 .4362
Carbonyl Iron 50 8.808 .4285
Imferon Iron 50 8.712 .4260
F=0.95 
P=0.42
Total 200 8.786 .4354
One   way Analysis of Variance F-test
The difference was not significant proved by F test
F = 0.95
P = 0.42
INITIAL HB
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COMPARISON OF INCREASE IN HAEMOGLOBIN
The  gestational  age,  initial  haemoglobin,  Bodymass  index,  being 
equalized in each group increase in Haemoglobin in each group was analysed.
Group A Ferrous Sulphate group :
70% of the patient showed 1 – 1.5gm% increase
Group B sodium Feredetate group :
50% of the patient showed 1 – 1.5 gm% increase
50% of the patient showed 1.6 – 1.9 gm% increase
Group C Carbonyl Iron
60% of the patient showed 1.6 – 2gm% increase 
Group D : Imferon group
60% of the patient showed 2 – 2.5gm% rise
Increase in Hb
Group
 
INCREASE Total
<1.0 1.0-1.5 1.5-2.0 >2.0  
Ferrous Sulphate 6 35 9 0 50
 
Sodium Feredetate 0 25 25 0 50
 
Carbonyl Iron 2 15 30 3 50
 
Imferon Iron 0 3 17 30 50
χ2=96.6  P = 0.001 P value is significant 
COMPARISON OF INITIAL AND FINAL HB
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Comparison of Increase in Hb%
S.No. Group Initial Final Difference Paired
t - test
1. Ferrous sulphate 8.85 ± 0.45 10.07±0.44 1.214±0.35 T=24.6 
P=0.001
2. Sodium 
Feredetate
8.77±0.44 10.25±0.48 1.484±0.31 T=34.2 
P=0.001
3. Carbonyl iron 8.81 ± 0.42 10.47  ± 
0.37
1.660 
±0.32
T = 37.8 
P = 0.001
4. Imferon iron 8.71 ± 0.43 10.75  ± 
0.45
2.038  ± 
0.33
T = 43.7 
P 0.001
The imferon group showed a better rise in haemoglobin than oral group. 
Carbonyl iron showed a better response than sodium Feredetate and ferrous 
sulphate group. The increase in haemoglobin was analysed using paired ‘T’ 
test. The above statement was proved. P values is significant.
DISCUSSION
Anaemia  is  the  commonest  medical  disorder  in  pregnancy.  Iron 
deficiency can be corrected by administration of iron. The goal of treatment is 
to increase haemoglobin levels as rapidly as possible.
Ferrous  sulphate  is  the  prevalent  iron  available  in  all  Government 
Institution and so the result obtained with other three iron is compared with 
ferrous sulphate.
 In our study only moderately anaemic patient are selected due to ethical 
reasons that severely anaemic pregnant women needs blood transfusion and 
repeated intramuscular injection. In our study all cases came for follow up.
Smear  study  in  all  the  four  groups  of  iron  showed  maximum  of 
microcytic  hypochromic  type  blood  picture,  next  to  that  is  normocytic 
hypochromic blood picture, is found in majority of patient which showed that 
nutritional iron deficiency anaemia is common in our antenatal mothers.
In our study parentral group i.e. imferon group showed a better rise in 
haemoglobin than oral group, 60% of the patient in imferon showed a rise of 2 
– 2.5gm where as 70% of the patient in ferrous sulphate group showed a rise of 
1 – 1.5gm%.
In a WHO sponsored collaborative studies on Nutritional  anaemia in 
India  by  Sood  SK,  Ramachandran  K,  Rani  –  K,  Ramalingasamy,  greater 
increase  in  haemoglobin  was  obtained  with parentral  administration  of  iron 
than with oral group.
In ICMR study conducted at Department of Obstetric and Gynaecology 
KGMU, Lucknow by Srivastava Aarti, Tandon prabba short intermuscular iron 
therapy improves haemoglobin levels, built up iron stores and maintains the 
rise till delivery better than oral iron.
Among  the  oral  group  carbonyl  iron  showed  a  better  response  than 
ferrous sulphate and sodium Feredetate.
60% in carbonyl iron group showed a rise of 1.6 – 2gm% where as in 
ferrous sulphate 70% showed a rise of 1 – 1.5gm%.
A  randomized  double  blind  study  regarding  bioavailability  of 
carbonyliron was done in female blood donors with iron deficiency anaemia 
overall  bioavailability of carbonyl iron is 70% that of ferrous sulphate.  The 
study  was  conducted  in  Department  Of  Medicine  Ohio  Western  Research 
University. By Devasthali SD, Godeuk VR, Brittenhan GM.
Process of carbonyl iron absorbtion in rat duodenal mucous studied with 
imunostaining  for  ferritin  done  in  Department  of  Pathology  Okayama 
University,  Japan.  Showed  that  liver  ferritin  is  increased  after  oral 
administration of Carbonyl iron. Proving a better bioavailability.
High  dose  carbonyl  iron  for  iron  deficiency  anaemia  a  randomized 
double  blind trail  conducted by Gorduk V.R.,  Brittenham showed safety of 
carbonyl  iron  with  large  doses.  The  study  concluded  carbonyl  iron  is  an 
effective inexpensive treatment for iron deficiency anaemia is accompanied by 
tolerable  side  effects  and  may  have  advantage  over  other  iron  salts  by 
decreasing risk of iron poisoning in children.
In our study sodium Feredetate showed a better response than ferrous 
sulphate 50% of the patient in sodium Feredetate group showed 1.6 – 2gm% 
rise where 60% of the patient in ferrous group showed a risk of 1 – 1.6gm%. 
This was due to better absorbtion of iron mediated by chelator EDTA.
Our results was substantiated by following other studies.
The  effect  of  different  iron  fortificant  in  iron  fortified  rice.  Iron 
absorbtion  from  rice  fortified  with  different  iron  fortificants.  Eg.,  ferrous 
sulphate,  sodium feredetate,  ferrous  fumarate  with  radio  labeled  istope was 
studied  by  Trinidad  TP,  Valdez  DH,  Iron  absorbtion  was  better  with  rice 
fortified with sodium feredetate
Potential  role  of  sodium  feredetate  as  iron  fortificant  was  done  in 
Department  of  Medicine  Faculty  of  Health  Science,    University  of 
Witwatersrand in South Africa. Showed sodium EDTA in the dose range of 
food fortificant does not have toxic effect.  FAO/WHO expert committee on 
food additives concluded that Na EDTA was safe in fortification programme.
In our study regarding the side effect gastrointestinal side effects were 
more common in the oral group than the parentral group. In the parentral group 
all  the patients complained of pain at injection site,  discoloration of skin at 
injection side and arthralgia.  None had severe reaction like allergy,  itching, 
fever or anaphylaxis. In Imferon group to all those patient who complained on 
pain and arthralgia small doses of analgesic were prescribed.
Among the oral group. Gastrointestinal side effect was predominantly 
complained. 
38% of patient in ferrous sulphate group
32% of the patient in sodium feredetate
28% of the patient in carbonyl iron group.
The study drugs were well tolerated in all the group. All those patient 
who complained epigastric pain were asked to take the tablet along with food, 
constipation  was  managed  by  asking  the  patient  to  take  high  fibre  diet. 
Vomiting  and  diarrhoea  subsided  within  3  to  4  days  by  itself  no  specific 
medication  was given to  the  patient  to  stop that  reaccurance and education 
about anaemia was given to all those patient who complained of side effect.
Cost Benefit Analysis:
 The  cost  of  Imferon  amounts  to  Rs.100/-  the  syringes  and  needles 
account  for  about  Rs.90/-.  The  diclofenac  tablet  prescribed  for  side  effect 
amount to Rs.5 to Rs.10 total cost of treatment in parental group cost around 
Rs.200/- for 1 month/ patient.
The cost of ferrous sulphate tablet account to Rs.75/- for  1  month  / 
patient. The cost of carbonyl iron for 1 month amounts to Rs.300/- the cost of 
sodium Feredetate  for  1  month  /  patient  amounts  to  Rs.240/-  for  month  / 
patient,
Among oral iron carbonyl iron was expensive than other two group. But 
our study we found 70% of the patient in ferrous sulphate showed rise of 1 – 
1.5gm% which is  not  bad.  In  a country  like ours  where  anaemia is  widely 
prevalent anaemia can be cured with ferrous sulphate which is available free of 
cost in all Government set up and Primary Health Centres.
In our study advantages noted with oral iron group are
a) Needs no hospitalization for test dose
b) Needs no assistance of paramedical workers
c) Lower expenditure than parentral (ferrous sulphate)
d) Carbonyl iron shows better response with rise of 1.54 – 2gm%.
Disadvantages of oral group in our study :
a) Gastrointestinal side effects is noted
b) Patient needs reassurance and treatment of side effects during their 
visit at 2 weeks of treatment.
c) Prolonged treatment is needed
d) Haemoglobin rise was more in parentral group.
e) Carbonyl iron treatment is more expenditure than parentral iron  
Advantages of Parental Iron :
1. Iron administered as injection bypasses the Gastrointestinal tract so 
the compliance is good due to lack of gastrointestinal side effects.
2. Better rise of haemoglobin percentage
3. Treatment period is short.
In our study disadvantage of Parentral Group
1. Need for assistance in administrating the drug
2. Cost factor
3. Pain and Discolouration at injection site.
SUMMARY
Ferrous Sulphate - 70% of the patient had 1 – 1.5 gm% 
rise in haemoglobin per month
Sodium Feredetate - 50% of the patient had 1.6 – 2 gm% 
rise in haemoglobin per month
Carbonyl iron - 60% of the patient had 1.6 – 2 gm% 
rise in haemoglobin per month
Parentral iron - 60% of the  patient had a rise of 
2 – 2.5gm% per month
 Parentral group showed a better response than oral group.
 Among oral iron, carbonyl iron showed a better response.
 Expenditure of treatment was more with carbonyl iron.
 Ferrous sulphate was the cheaper iron.
 Gastro intestinal side effects was noted in all three groups of oral iron 
 Pain and discoloration of skin was complained by the parentral group.    
 Parentral iron administration needs hospitalization and the help of 
paramedical workers  
CONCLUSION
In our study among the oral groups efficacy of carbonyl iron and sodium 
feredetate  is  more  than ferrous  sulphate  but  the expenditure  of  treatment  is 
higher than ferrous sulphate which the patients in our setup cannot afford. The 
ferrous sulphate group showed a 1 – 1.5gm% rise in haemoglobin /  month, 
when screened at a earlier gestational age (24 – 32 weeks) anaemia of moderate 
grade can be effectively treated with ferrous sulphate at a lower cost.
The compliance and efficacy of parentral iron dextran is more than all 
three  oral groups. If the patient cannot tolerate oral iron we can change over to 
parentral iron which showed a better rise in haemoglobin.
PROFORMA  
Patients Name : Age :
Obstetric Status :
Address : LMP :
EDD :
Ht Wt BMI Gestational Age :
Type of Iron : Date of Starting Therapy :
Past History :
History of any disease in the past Yes No
If yes Specify the disease
Clinical Examination USG
Investigation :
1. Peripheral Smear
2. Haemoglobin % Day 0 Day 30
 
Side effects noted :
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